Press Release
ChamberMaster Doubles Down With Innovative Solutions to Foster Engagement, Boost Retention and Drive Revenue With AI
Chambers of Commerce Using ChamberMaster Software are Invited to Add Community Platform, AI-Newsletter Technology and More to Their Subscription in the Coming Months Read More
Press Release
REMORY, a Supplement Currently Receiving Widespread Attention, Announces Packaging Redesign for the U.S. Market
REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and Omega-3s for Enhanced Memory and Brain Function in Aging Adults. Recognized by Japan as a 'Food with Functional Claims,' REMORY is FDA-Notified, Setting a New Standard in Natural Cognitive Support. Read More
Press Release
Alset AI Provides Corporate and Operational Update
News Release Highlights: Alset AI is poised to receive CAD$3.7 million plus interest from its portfolio company, Cedarcross, in repayment of a secured loan, strengthening Alset's balance sheet and enhancing its capacity to pursue additional artificial intelligence investments. Alset AI's portfolio company Cedarcross secures an agreement to sell thirteen (13) Nvidia H100 HGX 8GPU servers to Ceti AI for an aggregate purchase price of approximately CAD$5,828,665. Alset AI's portfolio company, Cedarcross, finalizes an amended two-year AI compute leasing agreement. Read More
Press Release
Sparta Announces Significant Environmental Benefits Following the Latest Verification Process of The Carbon Program at Its E-Waste Processing Facility - ERS International
Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws Read More
Press Release
Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination
New campaign aims to inform and educate the public about the ongoing risks of COVID-19 and the impact the virus continues to have on day-to-day life Updated vaccines targeting KP.2 variant have been approved by the U.S. FDA and are now available across the country Read More
Press Release
Cerrado Gold Announces Q2 Financials, Cashflow and Operating Cost Performance at Its Minera Don Nicolas Mine in Argentina
Gold equivalent production of 16,255 GEO for Q2; On track for Full year guidance of 50,000-60,0000 GEO Adjusted EBITDA of $14.7 million for Q2 Operating results for Q2 highlight stable operating performance which is expected for the remainder of the year Recent 43-101 Mineral Resource Update and Preliminary Economic Assessment Completed for MDN showing an NPV5% of $111MM at $2,100 oz gold price over a 5 year mine life Read More
Press Release
Keystone Private Wealth Expands Expertise with the Addition of Two Veteran Financial Advisors
Keystone Private Wealth Strengthens Its Team with the Addition of Veteran Advisors Robert Valenzuela and Todd Luttmers, Enhancing Client-Focused Financial Strategies and Service Excellence Read More
Press Release
MMJ's FDA Marijuana Clinical Trials: A Sure Bet Amid Industry Uncertainty and DEA's Contradictions
MMJ International Holdings has submitted to the FDA for approval of its soft gelatin capsule to be used in clinical trails for its Huntington Disease Study. MMJ has received an Orphan designation from the FDA. Once FDA approved the company will be one of a very few with federal authorization to sell its medication. Read More
Press Release
